Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Biogen Stock Hits Fresh High on Eli Lilly Buzz
10:59am, Wednesday, 03'rd May 2023
The shares of Biogen Inc (NASDAQ:BIIB) are enjoying tailwinds from positive news surrounding sector peer Eli Lilly's (LLY) Alzheimer's drug donanemab.
Cramer's First Take: Eli Lilly's Alzheimer's drug is 'the holy grail'
10:54am, Wednesday, 03'rd May 2023
CNBC's Jim Cramer shares his thoughts on Eli Lilly's Alzheimer's drug and the banking turmoil.
Eli Lilly's Results Signal Arrival of Blockbuster New Drug Class
10:16am, Wednesday, 03'rd May 2023
The company's Alzheimer's drug results might look better than Biogen's, but both makers will likely benefit.
Eli Lilly's Alzheimer's drug slowed cognitive decline in phase 3 study
09:56am, Wednesday, 03'rd May 2023
Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's Alzheimer's treatment donanemab, which slowed disease progression in the phase 3 trial.
LLY Stock Alert: Eli Lilly Announces Positive Alzheimer's Drug Data
09:44am, Wednesday, 03'rd May 2023
Eli Lilly (NYSE: LLY ) stock is getting a boost on Wednesday after the company announced results from an Alzheimer's clinical trial. The big news traders are celebrating is the effectiveness of donane
Eli Lilly Surges After Alzheimer's Treatment Succeeds; Biogen Also Rises
09:16am, Wednesday, 03'rd May 2023
Eli Lilly stock popped Wednesday after the company said its experimental Alzheimer's treatment significantly slowed cognitive decline. The post Eli Lilly Surges After Alzheimer's Treatment Succeeds; B
Good News for Patients Is Lifting These 2 Biopharma Stocks
08:46am, Wednesday, 03'rd May 2023
Markets were waiting to see what the Federal Reserve will do with interest rates later today. Eli Lilly announced favorable trial results for its Alzheimer's treatment.
U.S. stock futures inch higher as traders await Fed decision
08:37am, Wednesday, 03'rd May 2023
U.S. stock index futures on Wednesday were recovering a portion of the previous session's sharp selloff, as the focus turns to the Federal Reserve interest rate decision later in the day, while privat
Eli Lilly jumps upon Alzheimer trial results, AMD, Starbucks and Ford drop after earnings, and other stocks on the move
07:48am, Wednesday, 03'rd May 2023
Livent Corp. shares LTHM jumped nearly 10% premarket Wednesday after the lithium miner posted first-quarter results that topped Wall Street views and raised guidance.
Eli Lilly Stock Jumps on Positive Alzheimer's Drug Phase 3 Trial Data
06:34am, Wednesday, 03'rd May 2023
The company says a Phase 3 study shows that donanemab 'significantly slowed cognitive and functional decline' in people with early symptomatic Alzheimer's disease.
Eli Lilly stock jumps 4% premarket on news of positive results in late-stage trial of Alzheimer's disease treatment
06:14am, Wednesday, 03'rd May 2023
Eli Lilly & Co.'s stock LLY jumped 4% premarket Wednesday, after the company announced positive data from a late-stage trial of its Alzheimer's disease treatment donanemab. The company said the Phase
3 Stocks Quietly Hitting All-Time Highs (and Can Continue Higher)
06:00am, Wednesday, 03'rd May 2023
It's been a tough 12 to 18 months for investors. The market roared higher into the end of 2021, stumbled big time in 2022, and had a strong start to 2023.
Eli Lilly Alzheimer's treatment donanemab slowed disease progression in clinical trial
06:00am, Wednesday, 03'rd May 2023
Donanemab, a monthly antibody infusion made by pharmaceutical company Eli Lilly, also significantly reduced brain plaque associated with Alzheimer's disease.
Can-Fite BioPharma Spikes on Pancreatic Cancer Inhibition Finding
01:12pm, Tuesday, 02'nd May 2023
Can-Fite BioPharma Ltd. NYSEAMERICAN: CANF is an Israel-based biotechnology firm that develops small-molecule therapeutic treatments for cancers, inflammatory diseases and sexual dysfunction.
Is Eli Lilly a Smart Dividend Stock to Buy Now?
09:45am, Tuesday, 02'nd May 2023
Eli Lilly is facing stiff but short-term headwinds to its earnings. Its dividend isn't in any danger, and it'll likely continue to rise -- and quickly.
